Skip to main content

Opportunity for blind/low vision kids to learn about government

I'm passing this information along to any readers who might be interested. It sounds like a great opportunity.

The National Federation of the Blind Announces the 2011 NFB Leadership and Advocacy in Washington, D.C., (LAW) Program





Engaging the Voice of America’s Blind Youth




April 8-12, 2011




Applications are due by February 1, 2011.




This four-day experience will provide blind and low-vision students in grades six to nine, or ages twelve to sixteen, with a unique opportunity to explore the inner workings of our country’s government, its history, and its culture, while staying at the headquarters for the National Federation of the Blind in Baltimore, Maryland. In addition to learning about grassroots legislation efforts, how resolutions are passed, and how blindness legislation is created, participants will become familiar with advocacy work for blind individuals and available resources for blind students and adults. Highlights of the program include: visits to historical sites in Washington, D.C., meetings with influential government leaders, presentations by prominent leaders from the largest blindness advocacy group in the country, a tour of the National Federation of the Blind national headquarters, and opportunities to interact with technology from the International Braille and Technology Center, the largest lab of Braille and speech products for the blind.


Twenty-four students will be accepted for the LAW program. All accepted students must be accompanied by a parent/guardian, teacher, or blind/low-vision mentor from their home state. There will be a $250 fee per student/chaperone pair. Transportation, room, and board will be provided for students and chaperones.




Apply now by going to www.nfb.org/LAWProgram. For more information, contact Treva Olivero, Education Program Specialist, at (410) 659-9314, extension 2295, or by e-mail at teolivero@nfb.org.






















Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria